Anzeige
Mehr »
Dienstag, 16.09.2025 - Börsentäglich über 12.000 News
Die Ethereum-Vorreiter: Wie Republic Technologies die Infrastruktur der Zukunft aufbaut
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
140 Leser
Artikel bewerten:
(0)

Katherine Brahan: Kelly Keegan Joins Qr8 Health as Chief Commercial Officer

Keegan to Lead Strategic Growth and Drive AI-Enabled Innovation in Digital Cognitive Health Solutions

CLEVELAND, OH / ACCESSWIRE / October 8, 2024 / Qr8 Health announced the appointment of Kelly Keegan as Chief Commercial Officer (CCO). Keegan brings more than 30 years of experience as a dynamic and entrepreneurial leader in the healthcare industry. His career is marked by significant contributions to building and expanding organizations in developing healthcare markets.

Kelly Keegan

Kelly Keegan
Kelly Keegan, Qr8 Health CCO



In his new role, Keegan will oversee commercial operations and lead strategic growth initiatives, driving the continued expansion of the company's innovative digital cognitive health solutions. With extensive experience collaborating with payers, providers, and health systems, Keegan is well-prepared to lead Qr8 Health's efforts. His focus will be on delivering first-of-its-kind, AI-enabled cognitive care tools that transform how patients with dementia are managed and create new revenue opportunities across multiple healthcare channels.

Keegan's background includes senior roles at The Clinic by Cleveland Clinic, PrescribeWellness, Xerox Health, and Anthem BCBS, where he focused on growth strategies and the development of healthcare solutions that empower patients and providers alike. His passion for improving individual lives through innovative healthcare solutions aligns perfectly with Qr8 Health's mission to transform cognitive assessment and care delivery through Qr8 Cognition Suite.

"I am truly excited to join Qr8 Health at such a crucial time," Keegan said. "Our innovative digital solutions are transforming cognitive care, and I'm eager to expand our impact across healthcare organizations looking to elevate patient outcomes and unlock new revenue streams. By driving forward-thinking innovation, we will not only enhance clinical results for patients affected by dementia but also ensure the long-term viability and growth of healthcare systems."

Vincent Owens, Chairman and Chief Executive Officer of Qr8 Health, said, "Kelly's leadership will be instrumental in advancing the company's mission and positioning Qr8 Health for continued growth. His proven track record and deep understanding of healthcare markets make him an invaluable addition to our team. I am confident his guidance will help us redefine the standard for digital cognitive assessment and care."

With Keegan leading commercial operations and partnership acquisition, Qr8 Health is poised to expand its footprint and continue providing top-tier cognitive solutions that help healthcare providers deliver better patient outcomes and support both value-based care and fee-for-service practice models.

About Qr8 Health
Founded in 2016, Qr8 Health provides innovative digital solutions to improve early detection, diagnosis, and management of cognitive and neurological conditions. Our flagship asset, Qr8 Cognition Suite, developed with Cleveland Clinic, integrates seamlessly into clinical workflows, providing an end-to-end care solution for early assessment to ongoing management of the patient. The platform's AI-enhanced capabilities align care plans with patient needs, helping both patients and providers navigate potential high-risk conditions with evidence-based strategies.

For more information, visit qr8health.com.

Contact Information
Katherine Brahan
Senior Manager, Marketing
kbrahan@qr8health.com
412-605-2437

SOURCE: Qr8 Health

.

View the original press release on newswire.com.

© 2024 ACCESS Newswire
Epische Goldpreisrallye
Der Goldpreis hat ein neues Rekordhoch überschritten. Die Marke von 3.500 US-Dollar ist gefallen, und selbst 4.000 US-Dollar erscheinen nur noch als Zwischenziel.

Die Rallye wird von mehreren Faktoren gleichzeitig getrieben:
  • · massive Käufe durch Noten- und Zentralbanken
  • · Kapitalflucht in sichere Häfen
  • · hohe Nachfrage nach physisch besicherten Gold-ETFs
  • · geopolitische Unsicherheit und Inflationssorgen

Die Aktienkurse vieler Goldproduzenten und Explorer sind in den vergangenen Wochen regelrecht explodiert.

Doch es gibt noch Titel, die Nachholpotenzial besitzen. In unserem kostenlosen Spezialreport erfahren Sie, welche 3 Goldaktien jetzt besonders aussichtsreich sind und warum der Aufwärtstrend noch lange nicht vorbei sein dürfte.

Laden Sie jetzt den Spezialreport kostenlos herunter und profitieren Sie von der historischen Gold-Hausse.

Dieses Angebot gilt nur für kurze Zeit – also nicht zögern, jetzt sichern!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.